Skip to content

Pragmatic Randomized Controlled Trial of Pharmacopuncture Therapy for Adhesive Capsulitis : A Pilot Study

Pragmatic Randomized Controlled Trial of Pharmacopuncture Therapy for Adhesive Capsulitis : A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05292482
Enrollment
21
Registered
2022-03-23
Start date
2022-04-20
Completion date
2022-12-06
Last updated
2023-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive Capsulitis

Brief summary

This is a 2-arm parallel pragmatic randomized controlled trial that will compare pharmacopuncture therapy with physical therapy for adhesive capsulitis.

Detailed description

Participants who voluntarily signed informed consent form and eligible for the study were randomly assigned in a 1:1 ratio (25:25) for pharmacopuncture therapy and physical therapy group. Participants of each group will receive twice a week for total 6 weeks of intervention. This is a pragmatic randomized controlled trial, so physicians will have medical decision making according to each participant's conditions.

Interventions

This is a pragmatic RCT, so the physicians will choose the type and volume of pharmacopuncture according to participants' conditions.

PROCEDUREphysical therapy

This is a pragmatic RCT, so the physicians will choose the type and time of physical therapy according to participants' conditions.

Sponsors

Korea Institute of Oriental Medicine
CollaboratorOTHER_GOV
Jaseng Hospital of Korean Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* Limitation of the shoulder movement (active or passive) * Numeric Rating Scale (NRS) of neck pain is more than 5 * Symptoms of adhesive capsulitis for more than 1 month * Discrimination findings which can explain clinical symptoms on shoulder MRI or CT * 19-69 years old * participants who agreed and wrote informed consents

Exclusion criteria

* Case of being diagnosed with a specific serious disease that may cause shoulder pain(Fracture, Dislocation, etc.) * Cause of pain due to soft tissue disease, not the spine(Cancer, fibromyalgia, RA, goat, or etc.) Other chronic diseases(stroke, MI, kidney disease, diabetic neuropathy, dimentia, epilepsy, or etc.) that may interfere with the interpretation of therapeutic effects or outcomes * Participants taking steroid, immunosuppressant, psychotropic medication, or taking other drugs that may affect outcomes * Inappropriate or unsafe pharmacopuncture therapy; hemorrhagic disease, taking anticoagulant drug, or severe diabetes patients who are likely to be infected * Participants who took NSAIDs or pharmacopuncture, acupuncture, physical therapy within 1 week * Pregnant, planning to get pregnant or lactating women * Participants who had undergone shoulder surgery within 3 months * Participants who had participated in other clinical trial within 1 month, had participated in other study within 6 months from the date of selection, or have plan for participation in other trial during follow up period of this trial * Participants who can not write informed consent * Participants who is difficult to participate in the trial according to investigator's decision

Design outcomes

Primary

MeasureTime frameDescription
Numeric rating scale (NRS) of shoulder painweek 7NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.

Secondary

MeasureTime frameDescription
ROM(Range of motion)week 1, 2, 3, 4, 5, 6, 7, 13The range of shoulder movement shows the function of the shoulder capsule.
SPADIweek 1, 7, 13SPADI is a functional disability questionnaire. The possible range of each item score is 0 to 10. Total score range is 0 (better outcome) to 100 (worse outcome).
Visual analogue scale (VAS) of shoulder painweek 1, 2, 3, 4, 5, 6, 7, 13Visual analogue scale of shoulder pain, minimum 0 to maximum 100, which is a higher score means a worse outcome.
SF-12 v2week 1, 7, 13The SF-12 consists of 12 questions across 8 domains, and higher scores indicate better health-related quality of life.
EQ-5D-5Lweek 1, 7, 13The EQ-5D-5L consists of 5 questions (mobility, self-care, usual activities, pain, anxiety/depression) that ask about the current state of health, and answers each question with 5 likert. (1=I have no problems about, 2=I have slight problems about, 3=I have moderate problems about, 4=I have severe problems about, 5=I am unable to about)
PGICweek 7, 13Participants rate the improvement after treatment on a 7-point Likert scale (1, very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; 6, much worse; or 7, very much worse.)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026